| Lastest Insider Transactions Of NEKTAR THERAPEUTICS ( NKTR ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-11-21 | Sell | 1,157 | 54.28 | 62,802 | 2025-11-25 20:30:55 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2025-11-21 | Sell | 630 | 54.28 | 34,196 | 2025-11-25 20:29:54 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-11-21 | Sell | 2,207 | 54.28 | 119,796 | 2025-11-25 20:28:44 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-11-21 | Sell | 2,207 | 54.28 | 119,796 | 2025-11-25 20:28:44 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-09-09 | Sell | 6,666 | 46.69 | 311,214 | 2025-09-11 21:01:44 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-09-09 | Sell | 6,666 | 46.69 | 311,214 | 2025-09-11 21:01:44 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-09-04 | Sell | 1,721 | 33.52 | 57,693 | 2025-09-08 20:32:09 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-09-04 | Sell | 11,832 | 36.42 | 430,959 | 2025-09-08 20:31:33 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-09-02 | Sell | 485 | 30.10 | 14,599 | 2025-09-04 21:02:14 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-09-02 | Sell | 1,500 | 30.16 | 45,240 | 2025-09-04 21:01:15 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-08-19 | Sell | 725 | 26.59 | 19,278 | 2025-08-21 21:05:34 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2025-08-19 | Sell | 676 | 26.59 | 17,975 | 2025-08-21 21:04:44 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-08-19 | Sell | 1,573 | 26.59 | 41,826 | 2025-08-21 21:03:49 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-08-19 | Sell | 1,573 | 26.59 | 41,826 | 2025-08-21 21:03:49 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-08-19 | Sell | 1,573 | 26.59 | 41,826 | 2025-08-21 21:03:49 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-08-19 | Sell | 1,573 | 26.59 | 41,826 | 2025-08-21 21:03:49 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-08-19 | Sell | 1,573 | 26.59 | 41,826 | 2025-08-21 21:03:49 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-05-19 | Sell | 10,712 | 0.67 | 7,177 | 2025-05-21 20:08:34 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2025-05-19 | Sell | 9,996 | 0.67 | 6,697 | 2025-05-21 20:07:50 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-05-19 | Sell | 23,208 | 0.67 | 15,549 | 2025-05-21 20:07:02 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2025-02-19 | Sell | 10,300 | 1.01 | 10,403 | 2025-02-21 18:07:52 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2025-02-19 | Sell | 11,040 | 1.01 | 11,150 | 2025-02-21 18:06:43 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2025-02-19 | Sell | 23,774 | 1.01 | 24,012 | 2025-02-21 18:04:25 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2024-12-23 | Sell | 49,962 | 0.90 | 44,800 | 2024-12-26 19:04:25 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2024-12-19 | Sell | 51,115 | 0.94 | 48,048 | 2024-12-20 20:33:46 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2024-12-17 | Sell | 132,030 | 1.00 | 131,650 | 2024-12-19 21:08:56 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2024-11-19 | Sell | 7,785 | 1.01 | 7,863 | 2024-11-20 20:37:21 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2024-11-19 | Sell | 6,407 | 1.01 | 6,471 | 2024-11-20 20:36:53 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2024-11-19 | Sell | 16,278 | 1.01 | 16,441 | 2024-11-20 20:36:22 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2024-08-19 | Sell | 6,866 | 1.28 | 8,788 | 2024-08-20 21:15:41 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2024-08-19 | Sell | 5,651 | 1.28 | 7,233 | 2024-08-20 21:15:13 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2024-08-19 | Sell | 14,881 | 1.28 | 19,048 | 2024-08-20 21:14:28 |
| NKTR | NEKTAR THERAPEUTICS | CHESS ROBERT | Directior | 2024-06-14 | Sell | 19,500 | 1.20 | 23,400 | 2024-06-14 18:02:51 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2024-05-17 | Sell | 16,650 | 1.75 | 29,138 | 2024-05-20 21:14:06 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2024-05-17 | Sell | 7,355 | 1.75 | 12,871 | 2024-05-20 21:13:22 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2024-05-17 | Sell | 6,260 | 1.75 | 10,955 | 2024-05-20 21:12:44 |
| NKTR | NEKTAR THERAPEUTICS | Deep Track Capital, LP | 10% Owner | 2024-05-10 | Sell | 56,000 | 1.78 | 99,630 | 2024-05-13 16:36:00 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2024-02-20 | Sell | 9,014 | 0.68 | 6,130 | 2024-02-22 20:19:39 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2024-02-20 | Sell | 7,606 | 0.68 | 5,172 | 2024-02-22 20:17:52 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2024-02-20 | Sell | 20,033 | 0.68 | 13,622 | 2024-02-22 20:16:48 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2023-11-17 | Sell | 9,646 | 0.49 | 4,727 | 2023-11-20 21:02:09 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2023-11-17 | Sell | 7,179 | 0.49 | 3,518 | 2023-11-20 21:00:19 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2023-11-17 | Sell | 19,877 | 0.49 | 9,740 | 2023-11-20 20:58:39 |
| NKTR | NEKTAR THERAPEUTICS | Curet Myriam | Directior | 2023-09-18 | Sell | 4,359 | 0.69 | 3,008 | 2023-09-20 20:09:30 |
| NKTR | NEKTAR THERAPEUTICS | CHESS ROBERT | Directior | 2023-09-18 | Sell | 10,200 | 0.67 | 6,834 | 2023-09-20 20:08:24 |
| NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Directior | 2023-09-18 | Sell | 4,359 | 0.69 | 3,008 | 2023-09-20 20:06:32 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2023-08-16 | Sell | 9,703 | 0.78 | 7,568 | 2023-08-17 20:08:02 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2023-08-16 | Sell | 7,221 | 0.78 | 5,632 | 2023-08-17 20:07:16 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2023-08-16 | Sell | 19,998 | 0.78 | 15,598 | 2023-08-17 20:06:28 |
| NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Directior | 2023-06-14 | Sell | 30,000 | 0.57 | 17,100 | 2023-06-15 18:26:24 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2023-05-16 | Sell | 9,791 | 0.72 | 7,050 | 2023-05-17 20:29:50 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2023-05-16 | Sell | 7,543 | 0.72 | 5,431 | 2023-05-17 20:28:38 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2023-05-16 | Sell | 20,361 | 0.72 | 14,660 | 2023-05-17 20:27:07 |
| NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | 2023-02-16 | Sell | 10,484 | 3.00 | 31,452 | 2023-02-17 21:00:43 |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | 2023-02-16 | Sell | 8,275 | 3.00 | 24,825 | 2023-02-17 20:59:32 |
| NKTR | NEKTAR THERAPEUTICS | Thomsen Jillian B. | Chief Financial Officer | 2023-02-16 | Sell | 10,267 | 3.00 | 30,801 | 2023-02-17 20:58:41 |
| NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 2023-02-16 | Sell | 19,635 | 3.00 | 58,905 | 2023-02-17 20:57:54 |
